Dartmouth Hitchcock Medical Center in Lebanon, NH, now offers esketamine nasal spray, also known by its brand name Spravato, as a treatment for patients with treatment-resistant depression. While it’s not exactly known how and why it works, David Eiler, MD, a psychiatrist at DHMC and member of the Mood Disorders Consultation Clinic team, says patients who started taking Spravato are showing positive results, which include a faster response for reducing symptoms than conventional antidepressants. “For a subset of patients, it could be a life-altering medication,” he told WCAX-TV.
Gene, 80, a patient at DHMC, says he is one of those people for whom Spravato has been a game-changer, after grappling with depression for 45 years—which is why he is willing to share his story. “I would just love to have people not have to got through what I have gone through over the years,” he told reporter Adam Sullivan.
Original source can be found here.
Alerts Sign-up